I appreciate SB 504’s intent to modernize pharmacy practice, but I urge the committee to ensure that expanded dispensing authority and remote processing are paired with clear competency standards, transparent oversight, and safeguards that protect patient safety. Some sections reduce examination and regulatory requirements, and I encourage careful review to avoid creating gaps in accountability as the scope of practice evolves.
SB504
Senate · 2026 sessionRepublicanDied in SenatePharmacist dispensing and treatment center authorization
AIAuthorizes pharmacists to dispense certain anti-cancer medications, permits remote processing by advanced pharmacy technicians, revises pharmacy licensing and labeling requirements, and authorizes the establishment of experimental treatment centers under the right to try act.
(New Title) relative to the practice of pharmacy and the dispensing of certain medications by pharmacists, authorizing the establishment of experimental treatment centers, and permitting treatment of certain severe illness under the right to try act.
Status
Died — the House and Senate did not agree · May 21, 2026- ✓Introduced
- ✕Senate
- House
- Governor
- Law
Division of testimony
21 submissionsI am a hospital clinical pharmacist and member of the NH Society of Health System Pharmacists and support this bill.
I support this SB504 as a Registered Pharmacist in New Hampshire
I have only recently become aware of this bill, but I would like to offer my support as a member of the public who has taken a growing interest in legislation related to pharmacists and healthcare. As a mother of five, I’ve seen firsthand how costly and inefficient routine care can be. After a recent doctor’s visit for my daughter to test for strep throat, we received a bill of over $500 for a simple diagnostic service. Situations like this highlight the need for more accessible, flexible care options. While I understand SB 504 is not specifically about expanding test-and-treat services, I strongly support its broader goal of modernizing pharmacy practice. Enabling pharmacists to operate with greater flexibility, in alignment with current technology and healthcare needs, is a practical step forward. Policy should keep pace with innovation. Expanding the role of pharmacists where appropriate can increase access, reduce unnecessary burdens on higher-cost care settings, and ultimately help lower healthcare costs for families like mine. For these reasons, I encourage you to support SB 504.
I support this bill as a licensed pharmacist in the state of New Hampshire
SB 504 modernizes outdated pharmacy laws to reflect current clinical practices. As an LTC pharmacist, I believe this bill is vital for reducing administrative burdens and allowing for more flexible, technology-driven patient care in New Hampshire.
Dear House Executive Departments and Administration Committee, I greatly support this bill, especially the added language: "Performance of the act is within the accepted standard of care that would be provided in a similar setting by a reasonable and prudent individual with similar education, training, and experience." I recently participated in a joint collaborative national summit with the American Society of Health System Pharmacists, the American Pharmacists Association, and National Association of Boards of Pharmacy, Implementing Solutions Summit 2.0. I am not speaking on their behalf, but as a summit participant and NH citizen. One of the most challenging barriers that faces our pharmacy profession since the pandemic are workplace conditions fueling stress and burnout across all clinical practice settings. The goal of this summit was to develop actionable solutions for employers, associations, boards of pharmacy to implement within their spheres of influence. One of the domains that resulted from the summit involved regulatory and legislative framework. A standard-of-care regulatory model, already implemented in other states such as Idaho, is a flexible approach to regulation that allows personnel to perform a wide range of services aligned with their level of experience and training. This necessitates a broad definition of the practice of pharmacy, allowing elasticity for practice innovation over time. This also limits prescriptive regulations and eliminates unnecessary regulations. Pharmacy personnel are expected to use their professional judgment, and this requires accountability for deviations from the standard of care. The language in SB504 aligns with the recommendations from this summit and would wholeheartedly encourage committee members to support this. Thank you for your time.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.